ACR appropriateness Criteria® pediatric Hodgkin lymphoma

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000368 ◽

2017 ◽

Vol 40 (1) ◽

pp. 108

Keyword(s):

Hodgkin Lymphoma ◽

Stage I ◽

Favorable Prognosis ◽

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000331 ◽

2016 ◽

Vol 39 (6) ◽

pp. 535-544 ◽

Cited By ~ 3

Author(s):

Sughosh Dhakal ◽

Ranjana Advani ◽

Leslie K. Ballas ◽

Bouthaina S. Dabaja ◽

Christopher R. Flowers ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Stage I ◽

Favorable Prognosis ◽

ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma

Journal of the American College of Radiology ◽

10.1016/j.jacr.2014.07.038 ◽

2014 ◽

Vol 11 (11) ◽

pp. 1026-1033.e3 ◽

Cited By ~ 9

Author(s):

Chul S. Ha ◽

David C. Hodgson ◽

Ranjana Advani ◽

Bouthaina S. Dabaja ◽

Sughosh Dhakal ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000294 ◽

2016 ◽

Vol 39 (4) ◽

pp. 384-395 ◽

Cited By ~ 1

Author(s):

Kenneth B. Roberts ◽

Anas Younes ◽

David C. Hodgson ◽

Ranjana Advani ◽

Bouthaina S. Dabaja ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Clinical Stage ◽

Stage I ◽

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Klinische Pädiatrie ◽

10.1055/s-0034-1371160 ◽

2014 ◽

Vol 226 (02) ◽

Author(s):

R Zhou ◽

A Ng ◽

R Weathers ◽

A McDonald ◽

W Leisenring ◽

...

Keyword(s):

Radiation Exposure ◽

Hodgkin Lymphoma ◽

Reduce Radiation Exposure ◽

Normal Tissues ◽

Lymphoma Therapy

Immunological Status of the Host in Aspect of Epstein-Barr Virus Latency in Pediatric Hodgkin Lymphoma

Klinische Pädiatrie ◽

10.1055/s-0034-1371105 ◽

2014 ◽

Vol 226 (02) ◽

Author(s):

T Klekawka ◽

W Balwierz

Keyword(s):

Hodgkin Lymphoma ◽

Epstein Barr Virus ◽

Barr Virus ◽

Immunological Status ◽

Virus Latency ◽

Epstein Barr

The GATLA (Argentinian Collaborative Group) experience through international cooperation in Pediatric Hodgkin Lymphoma (HL)

10.1055/s-0040-1701830 ◽

2020 ◽

Author(s):

D Veron ◽

P Streitenberger ◽

D Freigeiro ◽

M Castellanos ◽

M Metzger

Keyword(s):

Hodgkin Lymphoma ◽

International Cooperation ◽

Collaborative Group ◽

Group Experience

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Case Medical Research ◽

10.31525/ct1-nct04213209 ◽

2019 ◽

Author(s):

Keyword(s):

T Cell ◽

Drug Use ◽

Hodgkin Lymphoma ◽

Intravenous Infusion ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma ◽

Pediatric Hodgkin Lymphoma

Patient-Friendly Summary of the ACR Appropriateness Criteria: Jaundice

Journal of the American College of Radiology ◽

10.1016/j.jacr.2020.03.002 ◽

2020 ◽

Vol 17 (7) ◽

pp. e43

Author(s):

Patti Brossard ◽

Nina S. Vincoff

Keyword(s):

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer

Journal of the American College of Radiology ◽

10.1016/j.jacr.2021.02.016 ◽

2021 ◽

Vol 18 (5) ◽

pp. S212-S228

Author(s):

Yulia Lakhman ◽

Hebert Alberto Vargas ◽

Caroline Reinhold ◽

Esma A. Akin ◽

Priyadarshani R. Bhosale ◽

...

Keyword(s):

Vulvar Cancer ◽